Company intelligence / Profile preview

Labviva

Boston, Massachusetts, United Stateslabviva.com ↗

Ownership: Private
Development stage: Other

Overview

Labviva has established itself as a leading AI-powered digital marketplace and procurement platform serving the life sciences sector. Its technology enables pharmaceutical companies, biotech firms, academic research institutions, and laboratories to streamline purchasing of lab supplies—such as reagents, chemicals, antibodies—and manage inventory efficiently. Customers report significant cost savings (~20% in year one) and reduced administrative burden. The company has raised over $53M in venture funding through Series B. There are no clinical results since it does not develop therapeutics.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

TakedaBoston Lab Servicespartnerships with >150 suppliers including major brands in life science supply chain

Beyond the preview

Go deeper on Labviva.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labviva.

Explore the full profile